Research & Development
Innovative Health launches B2B platform for at-home testing
Digital health organizations can utilize Innovative Health's partner platform to offer consumers more than 70 different at-home tests that detect conditions, including infectious diseases and women's and men's health concerns, the firm said.
September 20, 2022
Study to use genetic testing to evaluate heart disease
Researchers from Dignity Health's Chandler Regional Medical Center, Mercy Gilbert Medical Center, and St. Joseph's Hospital and Medical Center will gather approximately 2,000 DNA samples from men and women between the ages of 40 and 60 with no known history of heart disease. The samples will be analyzed for genetic markers known to cause heart disease at Baylor College of Medicine's Human Genome Sequencing Center Clinical Lab in Houston.
February 22, 2022
Labcorp launches online portal for patients
The OnDemand portal includes a suite of Labcorp's most popular tests, including for wellness, allergy, COVID-19, and women's health and fertility. The company is planning to add additional tests to Labcorp OnDemand later this year.
February 3, 2022
Labcorp acquires women's digital health firm Ovia
Ovia has developed a software platform designed to help individuals manage parenting and women's and family health. It includes features like reproductive cycle tracking, baby growth tracking, and fertility and pregnancy support.
August 12, 2021
Hologic buys Biotheranostics molecular testing firm
Acquiring Biotheranostics allows Hologic to enter the fast-growing oncology molecular testing market, according to the firm. It also fits well with the company's existing focus on women's health.
January 4, 2021
Canadian researchers develop test to track dietary fats
The test could help nutritional epidemiologists develop better guidelines for dietary fat consumption, especially for specific populations such as pregnant women, whose fat intake can affect the health of their babies, according to a team led by Philip Britz-McKibbin, PhD.
May 18, 2020
New POC test performs well for chlamydia, gonorrhea in women
The multisite study evaluated tests for the two common sexually transmitted infections (STIs) on Binx Health's benchtop polymerase chain reaction (PCR) instrument, which delivers results in 30 minutes. The U.S. Food and Drug Administration (FDA) approved use of the instrument in men last month, following clearance for use in women in August 2019. Validation data supporting the regulatory clearances were published by Johns Hopkins epidemiologist Charlotte Gaydos and colleagues.
May 14, 2020
Older women benefit from genetic breast cancer testing
The study addresses the question of who exactly should undergo breast cancer genetic testing, wrote a team led by Dr. Allison Kurian of Stanford University.
March 10, 2020
Opioid use doesn't prevent women from cancer screening
The findings speak to the concern that addressing patients' pain with opioid medications may diminish compliance with preventive health measures such as cancer screening, wrote a team led by Dr. Alicia Agnoli of the University of California, Davis (Ann Fam Medicine, January/February 2020, Vol. 18:1, pp. 59-65).
February 18, 2020
Could cervical cancer be eliminated in 20 years?
The findings suggest a way for the U.S. clinical community to actively respond to the World Health Organization's (WHO) 2018 charge to eliminate cervical cancer as a public health problem, wrote a team led by Emily Burger, PhD, of the Harvard T.H. Chan School of Public Health in Boston. The WHO's cervical cancer incidence target is four or fewer cases per 100,000 women-years.
February 10, 2020
Hormone blood test could pinpoint time of menopause
The investigators explored the potential of the picoAMH enzyme-linked immunosorbent assay (ELISA) research-use-only product (Ansh Labs) using data for 1,537 middle-aged women enrolled in the prospective, longitudinal Study of Women's Health Across the Nation (SWAN). Among many other kinds of health assessments tracked over time during the menopause transition period, SWAN entailed blood testing for AMH, an ovarian hormone, and follicle-stimulating hormone (FSH), a pituitary hormone.
January 22, 2020
Smartphones double as point-of-care diagnostics
The technical capabilities of these phones have become so advanced that they can compete with technology once thought to be only the domain of physicians' offices and hospitals. Research groups and startup companies are developing apps and technology that turn smartphones into tools that can diagnose eye disease, perform home-based urinalysis, diagnose ear infections and respiratory disease, and help women learn about their reproductive health.
December 1, 2019
Page 1 of 2